The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence
Open accessAbstract
Data are available such that choice of Helicobacter pylori therapy for an individual patient can be reliably predicted. Here treatment success is defined at a cure rate of 90% or greater. Treatment outcome in a population or a patient can be calculated based on the effectiveness of a regimen for infections with susceptible and with resistant strains coupled with knowledge of the prevalence of resistance (i.e., based on formal measurement, clinical experience, or both). We provide the formula for predicting outcome and we illustrate the calculations. Because clarithromycin-containing triple therapy and 10 day sequential therapy are now only effective in special populations they are considered obsolete; neither should continue to be used as empiric therapies (i.e., 7 and 14 day triple therapies fail when clarithromycin resistance exceeds 5% and 15%, respectively and 10-day sequential therapy fails when metronidazole resistance exceeds 20%). Therapy should be individualized base on prior history and whether the patient is in a high risk group for resistance. The preferred choices for Western countries are 14 day concomitant therapy, 14 day bismuth quadruple therapy, and 14 day hybrid sequential-concomitant therapy. We also provide details regarding the successful use of fluoroquinolone-rifabutin-, and furazolidone-containing therapies. Finally, we give recommendations for efficient development (i.e., identification and optimization) of new regimens as well as how to prevent or minimized failures. The trial and error approach for identifying and testing regimens frequently resulted in poor treatment success. The approach described allows outcome to be predicted and should simplify treatment and drug development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Atherton, J., Axon, A. T. R., Bazzoli, F., Gensini, G. F., Gisbert, J. P., Graham, D. Y., Rokkas, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-302084 · Cited by 2,266
Self-citationMegraud, F., Coenen, S., Versporten, A., Kist, M., Lopez-Brea, M., Hirschl, A. M., Andersen, L. P., Goossens, H., Glupczynski, Y., & on behalf of the Study Group participants (2013) · Gut · doi:10.1136/gutjnl-2012-302254 · Cited by 839
Intention-to-treat analysis and the goals of clinical trials*
Sheiner, L. B., & Rubin, D. B. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90260-0 · Cited by 314
Jafri, N. S., Hornung, C. A., & Howden, C. W. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-12-200806170-00226 · Cited by 296
Gatta, L., Vakil, N., Leandro, G., Mario, F. D., & Vaira, D. (2009) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.555 · Cited by 274
Liou, J.-M., Chen, C.-C., Chen, M.-J., Chen, C.-C., Chang, C.-Y., Fang, Y.-J., Lee, J., Hsu, S.-J., Luo, J.-C., Chang, W.-H., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61579-7 · Cited by 269
Self-citationGreenberg, E. R., Anderson, G. L., Morgan, D. R., Torres, J., Chey, W. D., Bravo, L. E., Dominguez, R. L., Ferreccio, C., Herrero, R., Lazcano-Ponce, E. C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60825-8 · Cited by 257
Evaluation of treatment regimens to cure Helicobacter pylori infection—a meta‐analysis
Laheij, Rossum, L. G. M. V., Jansen, Straatman, & Verbeek (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00542.x · Cited by 256
Fuccio, L., Minardi, M. E., Zagari, R. M., Grilli, D., Magrini, N., & Bazzoli, F. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00008 · Cited by 248
Optimal therapy for Helicobacter pylori infections
Rimbara, E., Fischbach, L. A., & Graham, D. Y. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.210 · Cited by 234
Self-citation
Cited by
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Gisbert, J. P., Kuipers, E. J., Axon, A. T., Bazzoli, F., Gasbarrini, A., Atherton, J., Graham, D. Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312288 · Cited by 2,946
Self-citationKyoto global consensus report on Helicobacter pylori gastritis
Sugano, K., Tack, J., Kuipers, E. J., Graham, D. Y., El-Omar, E. M., Miura, S., Haruma, K., Asaka, M., Uemura, N., & Malfertheiner, P. (2015) · Gut · doi:10.1136/gutjnl-2015-309252 · Cited by 1,876
Self-citationACG Clinical Guideline: Treatment of Helicobacter pylori Infection
Chey, W. D., Leontiadis, G. I., Howden, C. W., & Moss, S. F. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.563 · Cited by 1,604
Lee, Y.-C., Chiang, T.-H., Chou, C.-K., Tu, Y.-K., Liao, W.-C., Wu, M.-S., & Graham, D. Y. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.028 · Cited by 1,013
Self-citationLanas, A., & Chan, F. K. L. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32404-7 · Cited by 984
Metadata
- Authors
- Graham, D. Y., Lee, Y., & Wu, M.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 12
- Issue
- 2
- Pages
- 177-186.e3
- ISSN
- 1542-3565 (ISSN-L)
- OpenAlex
- W1982900653
- Cited by
- 347
- References
- 25
- FWCI
- 32.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence. https://app.cochat.ai/papers/10.1016/j.cgh.2013.05.028
- The paper
- Graham, D. Y., Lee, Y., & Wu, M. (2014). Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2013.05.028
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.